Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about STRESS GRANULES: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | STRESS GRANULES |
| Key Genes/Proteins | ATXN2, CLPP, ELAVL4, FMRP, G3BP1 |
| Related Diseases | AMYOTROPHIC LATERAL SCLEROSIS, cancer, disease, Gastric Cancer, Glioma |
| Related Pathways | CALCIUM SIGNALING, Drug Resistance |
graph TD
STRESS_GRANULES["STRESS GRANULES"]
style STRESS_GRANULES fill:#1a237e,stroke:#4fc3f7,stroke-width:3px
STRESS_GRANULES -->|"involved_in"| Prostate_Cancer["Prostate Cancer"]
STRESS_GRANULES -->|"modulates"| Senescence["Senescence"]
STRESS_GRANULES -->|"involved_in"| TDP_43([TDP-43])
STRESS_GRANULES -->|"mediates"| Cellular_Stress_Response["Cellular Stress Response"]
STRESS_GRANULES -.->|"inhibits"| Protein_Translation["Protein Translation"]
STRESS_GRANULES -->|"involved_in"| Glioma["Glioma"]
STRESS_GRANULES -->|"component_of"| Stress_Granule_Assembly["Stress Granule Assembly"]
STRESS_GRANULES -->|"activates"| ChaC2_Translation["ChaC2 Translation"]
STRESS_GRANULES -->|"regulates"| mRNA_Stability["mRNA Stability"]
PABP1_eIF4B_Complex([PABP1/eIF4B Complex]) -->|"involved_in"| STRESS_GRANULES
Liquid_Liquid_Phase_Separation["Liquid-Liquid Phase Separation"] -->|"involved_in"| STRESS_GRANULES
TRIM21([TRIM21]) -->|"regulates"| STRESS_GRANULES
G3BP1([G3BP1]) -->|"mediates"| STRESS_GRANULES
Phase_Separation["Phase Separation"] -->|"involved_in"| STRESS_GRANULES| Target | Relation | Type | Str |
|---|---|---|---|
| TDP-43 SUMO2/3 conjugation | promotes | process | 1.00 |
| Liquid-Liquid Phase Separation | involved_in | process | 0.95 |
| Cancer Progression | associated_with | process | 0.95 |
| Mrna Translation | regulates | process | 0.95 |
| Cellular Stress Response | involved_in | process | 0.95 |
| mRNA translation | regulates | process | 0.95 |
| Protein Synthesis | regulates | process | 0.95 |
| Mrna | associated_with | compound | 0.95 |
| Senescence | modulates | process | 0.95 |
| Drug Resistance | promotes | phenotype | 0.95 |
| Prostate Cancer | involved_in | disease | 0.95 |
| TDP-43 | involved_in | protein | 0.95 |
| Cellular Stress Response | mediates | process | 0.90 |
| Stress Granule Assembly | component_of | process | 0.90 |
| Prostate Cancer | promotes | disease | 0.90 |
| RNA | regulates | entity | 0.90 |
| Cellular Protection Mechanism | involved_in | mechanism | 0.90 |
| TDP-43 proteinopathy | mediates | disease | 0.90 |
| translation | inhibits | process | 0.90 |
| Cellular Damage | protects_against | phenotype | 0.90 |
| Protein Translation | inhibits | process | 0.90 |
| Glioma | associated_with | disease | 0.90 |
| ChaC2 Translation | activates | process | 0.87 |
| cancer cell survival | promotes | phenotype | 0.85 |
| Mrna Stability | regulates | mechanism | 0.85 |
| AR | modulates | receptor | 0.85 |
| mRNA Stability | regulates | mechanism | 0.85 |
| ChaC2 Translation | mediates | process | 0.85 |
| Docetaxel Resistance | promotes | phenotype | 0.85 |
| Prostate Cancer Progression | contributes_to | phenotype | 0.85 |
| Androgen Receptor | modulates | receptor | 0.85 |
| Gene Expression | regulates | mechanism | 0.85 |
| EIF2A | phosphorylates | gene | 0.85 |
| Neurodegeneration | involved_in | process | 0.85 |
| Viral Infections | implicated_in | disease | 0.85 |
| Germ Cell Development | regulates | process | 0.85 |
| CHAC2 | activates | gene | 0.85 |
| Drug Resistance | contributes_to | phenotype | 0.85 |
| glioma progression | drives | phenotype | 0.82 |
| viral infections | implicated_in | disease | 0.82 |
| Mrna Transport | regulates | process | 0.80 |
| SENESCENCE | interacts_with | entity | 0.80 |
| Androgen Receptor Signaling | modulates | pathway | 0.80 |
| Androgen Deprivation Therapy Sensitivity | modulates | phenotype | 0.80 |
| TDP-43 | mediates | protein | 0.80 |
| FUS | mediates | protein | 0.80 |
| Androgen Deprivation Therapy Resistance | promotes | phenotype | 0.80 |
| Cancer Cell Protection | protects_against | phenotype | 0.80 |
| ALZHEIMER'S DISEASE | associated_with | entity | 0.80 |
| PARKINSON'S DISEASE | associated_with | entity | 0.80 |
| Source | Relation | Type | Str |
|---|---|---|---|
| PABP1/eIF4B Complex | involved_in | protein | 0.95 |
| Lysosomal Damage | associated_with | phenotype | 0.95 |
| Eif4B | involved_in | protein | 0.95 |
| Liquid-Liquid Phase Separation | involved_in | mechanism | 0.95 |
| liquid-liquid phase separation | drives | process | 0.95 |
| G3BP1 | associated_with | protein | 0.95 |
| TRIM21 | regulates | protein | 0.95 |
| PABP1 | associated_with | protein | 0.95 |
| Pabp1/Eif4B Complex | involved_in | protein | 0.95 |
| TDP43 | involved_in | protein | 0.93 |
| Mutant FUS | associated_with | protein | 0.92 |
| translation initiation factors | involved_in | protein | 0.91 |
| Genetic Mutations | causes | variant | 0.90 |
| phase separation | mediates | process | 0.90 |
| Translation Initiation Factors | interacts_with | protein | 0.90 |
| HSPB8 | expressed_in | protein | 0.90 |
| TRIM21 | expressed_in | protein | 0.90 |
| Liquid-Liquid Phase Separation | promotes | process | 0.90 |
| G3BP1 | activates | protein | 0.90 |
| Ubiquitinated G3Bp1 | regulates | protein | 0.90 |
| Liquid-Liquid Phase Separation | mediates | mechanism | 0.90 |
| G3BP1 | activates | protein | 0.90 |
| G3BP1 | mediates | protein | 0.90 |
| Phase Separation | involved_in | process | 0.90 |
| FUS | associated_with | protein | 0.90 |
| Atxn2 Intermediate Expansions | associated_with | biomarker | 0.90 |
| TARDBP | interacts_with | protein | 0.90 |
| FUS | interacts_with | protein | 0.90 |
| G3BP1 | component_of | protein | 0.90 |
| Rna-Binding Proteins | interacts_with | protein | 0.85 |
| RNA-binding Proteins | involved_in | protein | 0.85 |
| MAPT | associated_with | gene | 0.85 |
| Mycobacterium Tuberculosis | associated_with | entity | 0.85 |
| Sars-Cov-2 Orf3A | associated_with | protein | 0.85 |
| Autophagy | degrades | process | 0.85 |
| TDP-43 | aggregates_with | protein | 0.80 |
| TDP-43 | co_localizes | protein | 0.80 |
| TDP-43 | induces_formation_of | protein | 0.80 |
| STAU2 | induces_formation | protein | 0.80 |
| TIA-1 | promotes | protein | 0.80 |
| TAU | associated_with | entity | 0.80 |
| TRIM21 | inhibits_formation | gene | 0.80 |
| ANXA11 | regulates | gene | 0.80 |
| Glioma | associated_with | disease | 0.80 |
| ATXN2 | regulates | gene | 0.80 |
| TAU | interacts_with | gene | 0.80 |
| EIF4B | associated_with | gene | 0.80 |
| TRIM21 | regulates | protein | 0.80 |
| autophagy | mediates_elimination | pathway | 0.80 |
| STING | regulates | gene | 0.70 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| C9orf72 DPRs Impair Autophagy Receptor Docking on Stress Gra | 0.717 | neurodegeneration | How do pathological stress granules in n |
| Differential Ubiquitin Chain Topology Creates 'Invisible' Su | 0.682 | neurodegeneration | How do pathological stress granules in n |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning STRESS GRANULES in their description or question text
No additional research found